Depression and adrenal function in spinal cord injury.

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Medicine

Background:

• Spinal cord injury (SCI) frequently leads to psychological distress.
• Depressive disorders are a significant concern for individuals with SCI, impacting quality of life and rehabilitation.
• Diagnostic accuracy for depression in SCI populations requires further investigation.

Purpose of the Study:

• To determine the prevalence of depressive disorders in patients with spinal cord injury.
• To evaluate the utility of the dexamethasone suppression test (DST) in diagnosing major depression among SCI patients.

Main Methods:

• A cohort of 32 patients with spinal cord injury was assessed.
• Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III) criteria were used for depressive disorder diagnosis.
• The dexamethasone suppression test was administered to patients with major depression.

Main Results:

• 14 out of 32 SCI patients (43.8%) received a DSM-III diagnosis of depressive disorder.
• Major depression was diagnosed in 12 patients, with 5 exhibiting melancholic features.
• Two patients were diagnosed with dysthymic disorder.
• The DST showed low sensitivity (30%) and specificity (50%) for major depression in this cohort.

Conclusions:

• Depressive disorders are highly prevalent in individuals following spinal cord injury.
• The dexamethasone suppression test is not a sensitive or specific biomarker for major depression in patients with spinal cord injury.
• Alternative or adjunctive diagnostic methods are needed for depression assessment in SCI patients.